Addex Therapeutics (ADXN) Receivables (2018 - 2026)
Addex Therapeutics (ADXN) recorded Receivables of $37,636 in Q2 2026, down 18.9% from $46,430 a year earlier and down 7.9% from the prior quarter.
Analysis
Addex Therapeutics (ADXN) Receivables (2018 - 2026) Analysis & Trends
At the end of FY2025, Addex Therapeutics reported Receivables of $25,132, down 60.8% from FY2024.
- Annual Receivables has declined for three straight years, with a five-year compound annual growth rate of -19.8% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $64,133 in FY2024 (-77.3%), $282,848 in FY2023 (-100.0%), $432.73 billion in FY2022 (+149.9%) and $173.13 billion in FY2021.
- Quarterly Receivables has ranged from $25,132 in Q4 2025 to $432.73 billion in Q4 2022 over the past five years.
- On a year-over-year basis, Receivables rose in 1 of the last seven quarters, with an average decline of 61.6%.
- Peak year-over-year performance for Receivables in the last five years was growth of 670.0% in Q3 2021, against a decline of 100.0% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $40,854 (Q1 2026), $25,132 (Q4 2025) and $64,064 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.96 Bn | 1,103.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 616.51 Bn | 535.04 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 501.10 Bn | 474.21 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 367.09 Bn | 321.47 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.10 Bn | 262.09 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.72 Bn | 235.40 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 235.73 Bn | 191.13 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 190.64 Bn | 164.84 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 169.63 Bn | 116.28 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Addex Therapeutics | 3.76 Mn | -3.20 Mn | - | 36,832.59 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36,832.59 |
| Mar 31, 2026 | 39,996.00 |
| Dec 31, 2025 | 25,371.98 |
| Sep 30, 2025 | 64,283.74 |
| Jun 30, 2025 | 48,154.09 |
| Mar 31, 2025 | 40,144.18 |
| Dec 31, 2024 | 17,174.84 |
| Sep 30, 2024 | 614,524.67 |
| Jun 30, 2024 | 686,048.16 |
| Mar 31, 2024 | 249,755.28 |
| Dec 31, 2023 | 179,363.49 |
| Sep 30, 2023 | 408,156.24 |
| Jun 30, 2023 | 284,333.90 |
| Mar 31, 2023 | 472,388.27 |
| Dec 31, 2022 | 581,757.58 |
| Sep 30, 2022 | 468,791.59 |
| Jun 30, 2022 | 485,881.05 |
| Mar 31, 2022 | 470,905.86 |
| Dec 31, 2021 | 322,627.79 |
| Sep 30, 2021 | 623,459.48 |
API Access
Addex Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ADXN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ADXN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ADXN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();